The interaction of specific co-activating proteins with AR, including JMJD2C, LSD1, 37CBP/P300, p160/SRC, and SUV39H2, can drive enhanced AR activation and the concomitant upregulation of the AR-dependent genes to augment tumor growth. The gene discussed is AR; the disease is neoplasm.